The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy
Abstract
In 1996 the prevalence, risk factors, and genotype distribution of hepatitis C virus (HCV) infection were assessed in the general population of a town in southern Italy. The sample was selected from the census by a systematic 1:4 sampling procedure. The participation rate was 96.6%. Among the 1,352 subjects enrolled, 195 (14.4%) tested reactive to antibody to HCV (anti-HCV) with enzyme immunoassay (EIA 3). When further tested with recombinant immunoblot assay (RIBA 3), 170 subjects (87.2%) tested positive, 23 subjects (11.8%) had indeterminate results, and 2 subjects (1%) tested negative. Thus, the overall anti-HCV EIA-positive RIBA-confirmed prevalence was 12.6% (170 of 1,352 subjects) and increased from 1.3% in subjects younger than 30 years to 33.1% in those ≥ 60 years of age. This latter age group accounted for 72.3% of all anti-HCV-positive subjects. Females tested positive more frequently than males (14.1% vs. 10.5%; P < .05). Alanine transaminase (ALT) concentrations were abnormal in only 4.1% (7/170) of anti-HCV EIA-positive RIBA-confirmed subjects. This suggests that ALT screening is not useful in the detection of anti-HCV-positive subjects in a general population. The results of multiple logistic regression analysis showed that an age of less than 45 years, the use of glass syringes, and dental therapy were all independent predictors of anti-HCV positivity. HCV RNA was detected by polymerase chain reaction in 75.9% of the 195 anti-HCV EIA-positive subjects: in 84.7% (144/170) of the RIBA-confirmed subjects; in 17.4% (4/23) tested as RIBA indeterminate; and in neither of the two subjects who tested RIBA negative. HCV type 1b was detected in 75 subjects (50.7%), type 2b in 1 subject (0.7%), type 2c in 66 subjects (44.6%), type 3a in 4 subjects (2.7%), and type 4 in two subjects (1.3%). These figures differ from those of Italian patients with chronic liver disease in whom genotype 2 is more rare. None of the individuals was infected with more than one genotype. The distribution of the two most common HCV viral types (1b and 2c) was not statistically different in terms of mean age, sex, or risk factors and suggests that they may have had a parallel spread in this community. These findings provide one of the highest overall anti-HCV prevalence rates in a general population with a likely cohort effect, i.e., decreased risk of infection along generations. These observations may indicate an epidemic or focus of hepatitis C that occurred several years earlier. The majority of anti-HCV-positive subjects in the oldest age group and with no clinical evidence suggests that HCV infection is a very prolonged and indolent disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y., Tanaka, T., Sato, K., Tsuda, F., Miyakawa, Y., et al. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-3-673 · Cited by 1,242
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Statistical Methods in Epidemiology
(2012) · SpringerReference · doi:10.1007/springerreference_205629 · Cited by 1,124
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Dusheiko, G., Schmilovitz-Weiss, H., Brown, D., McOmish, F., Yap, P.-L., Sherlock, S., McIntyre, N., & Simmonds, P. (1994) · Hepatology · doi:10.1002/hep.1840190104 · Cited by 561
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
McOmish, F., Yap, P. L., Dow, B. C., Follett, E. A., Seed, C., Keller, A. J., Cobain, T. J., Krusius, T., Kolho, E., & Naukkarinen, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.884-892.1994 · Cited by 509
Hepatitis C Virus Type 1b (II) Infection in France and Italy
Nousbaum, J.-B., Pol, S., Nalpas, B., Landais, P., Berthelot, P., Brechot, C., & and The Collaborative Study Group* (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-3-199502010-00001 · Cited by 489
Okamoto, H., Tokita, H., Sakamoto, M., Horikita, M., Kojima, M., Iizuka, H., & Mishiro, S. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-11-2385 · Cited by 383
Simonetti, R. G., Cammà, C., Fiorello, F., Cottone, M., Rapicetta, M., Marino, L., Fiorentino, G., Craxì, A., Ciccaglione, A., Giuseppetti, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-97 · Cited by 354
Self-citationPawlotsky, J.-M., Tsakiris, L., Roudot-Thoraval, F., Pellet, C., Stuyver, L., Duval, J., & Dhumeaux, D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1607 · Cited by 345
Survey Methods in Community Medicine
(1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.661.813-a · Cited by 289
Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 252
XIA, G., LIU, C., CAO, H., BI, S., ZHAN, M., SU, C., NAN, J., & QI, X. (1996) · International Hepatology Communications · doi:10.1016/s0928-4346(96)82012-3 · Cited by 240
Andersen, E. B. (1994) · The Statistical Analysis of Categorical Data · doi:10.1007/978-3-642-78817-8_9 · Cited by 188
Prati, D., Capelli, C., Zanella, A., Mozzi, F., Bosoni, P., PAPPALETTERA, M., Zanuso, F., Vianello, L., Locatelli, E., Fazio, C., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536854 · Cited by 131
Bac, C. D., Stroffolini, T., Gaeta, G. B., Taliani, G., & Giusti, G. (1994) · Hepatology · doi:10.1016/0270-9139(94)90761-7 · Cited by 131
Self-citationLogistic regression analysis of epidemiologic data: theory and practice
Kleinbaum, D. G., Kupper, L. L., & Chambless, L. E. (1982) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928208828251 · Cited by 118
Chiaramonte, M., Stroffolini, T., Lorenzoni, U., Minniti, F., Conti, S., Floreani, A., Ntakirutimana, E., Vian, A., Ngatchu, T., & Naccarato, R. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80020-1 · Cited by 115
Self-citationMolecular epidemiology of hepatitis C virus infection among intravenous drug users
Silini, E. M., Bono, F., Cividini, A., Cerino, A., Maccabruni, A., Tinelli, C., Bruno, S., Bellobuono, A., & Mondelli, M. U. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80225-8 · Cited by 73
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma
Stroffolini, T., Chiaramonte, M., Tiribelli, C., Villa, E., Simonetti, R. G., Rapicetta, M., Stazi, M. A., Bertin, T., Crocè, L. S., Trande, P., et al. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80670-1 · Cited by 64
Self-citationKaur, S., Rybicki, L. A., Bacon, B. R., et al. (1996) · Hepatology · doi:10.1002/hep.510240501 · Cited by 62
Cited by
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Self-citationUpdated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Compliance with Handwashing in a Teaching Hospital
Pittet, D., Mourouga, P., Perneger, T. V., & Program, A. T. M. O. T. I. C. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-2-199901190-00006 · Cited by 996
Metadata
- Authors
- Guadagnino, V, Stroffolini, T., Rapicetta, M., Costantino, A., Kondili, L. A., Menniti-Ippolito, F., Caroleo, B., Costa, C., Griffo, G., Loiacono, L., Pisani, V, Foca, A., & Piazza, M.
- Venue
- Hepatology
- Published
- 1997-10
- Volume
- 26
- Issue
- 4
- Pages
- 1006-1011
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2143174310
- Cited by
- 389
- References
- 24
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.